Gilead Sciences, Inc.

Gilead Sciences, Inc.

Gilead Sciences, Inc.

Overview
Date Founded

1987

Headquarters

333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404

Type of Company

Public

Employees (Worldwide)

11K

Industries

Biotechnology
Hospitals & Patient Services
Industrial Machinery & Manufacturing

Company Description

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Contact Data
Trying to get in touch with decision makers at Gilead Sciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Chief Financial Officer

Executive Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Executive Vice President, Chief Commercial Officer

Chief Scientific Officer & Head of Research & Development

Chief Medical Officer & Executive Vice President

Chief Medical Officer

Member, Senior Leadership Team

Executive Vice President, Human Resources

Executive Vice President, Research

Board of Directors

Chairman & Chief Executive Officer at Gilead Sciences, Inc.

Former President & Chief Executive Officer at Catholic Health Initiatives

Executive Vice President & Chief Financial Officer at Cisco Systems, Inc.

Senior Operating Partner at The Blackstone Group, Inc.

Arthur & Marian Hanisch Memorial Professor of Chemistry at California Institute of Technology

Former Professional at Atlantic Richfield Co., Inc.

Thomas W. & Susan B. Ford Distinguished Fellow at Hoover Institution

Director & Assistant Secretary at Gilead Sciences, Inc.

Paths to Gilead Sciences, Inc.
Potential Connections via
Relationship Science
You
Gilead Sciences, Inc.
Owners & Shareholders
Details Hidden

Capital World Global Investors (CWGI) is the investment adviser to the American Funds Group, a family of 30 funds marketed to individuals exclusively through financial advisers and other intermediaries. American Funds are also used as investment vehicles for 401ks, other retirement plans, variable annuities and 529 college savings plans. The funds have the following characteristics: (1) a long-term, value-oriented approach (2) long-established, global research (3) a multiple portfolio counselor system that combines teamwork with individual accountability (4) experienced, long-tenured investment professionals and (5) a commitment to low operating expenses, among the lowest in the fund industry. CWGI uses a Multiple Portfolio Counselor System. The assets of each fund are divided into smaller, more manageable portions. Each portion is managed by a portfolio counselor who operates autonomously, investing his or her portion as though it were an entire fund (subject to fund objectives and overall guidelines). Research analysts typically manage a segment as well, bringing their expertise directly to bear on the fund's results. Portfolio counselors are free to make their own decisions. As a fund's assets grow, new counselors can be added. Investment decisions are based on internal research. Equity research is comprehensive and bottom-up while at the same time constantly monitoring broader economic, political, currency and interest rate trends. Investment research is proprietary and used solely by CWGI portfolio managers.

Details Hidden

Dodge & Cox's investment decisions are made by a team of seasoned investment professionals based on key fundamental factors that they believe determine investment value over the long term. The firm's investment analysts operate from a single location to foster communication and collaboration and each investment idea is subject to committee review for both its merits as a specific investment and its role in the overall portfolio. Their approach stresses an evaluation of risk relative to opportunity and we seek investments that we believe are undervalued by the market. Fundamental bottom-up research, a rigorous valuation discipline and a long-term investment horizon are central to Dodge & Cox's investment philosophy.

Details Hidden

For the ICM Index-Based ETFs and Self-Indexed ETFs, ICM attempts to replicate, before fees and expenses, the price and yield of an Underlying Index. For many of the Index-Based ETFs, they employ a \"full replication\" methodology, meaning that the Index-Based ETF generally invests in all of the securities comprising its Underlying Index in proportion to the weightings of the securities in the Underlying Index. Due to the practical difficulties and expense of purchasing all of the securities in certain Index-Based ETF's Underlying Indexes, ICM utilizes a sampling methodology as the primary approach for seeking to track such Index-Based ETF's Underlying Index. A sampling methodology is also the primary approach utilized by the firm for the Self-Indexed ETFs. For the Actively Managed ETFs, they do not seek to fully replicate an Underlying Index but may use a quantitative-rules based investment strategy designed to provide returns that correspond to the performance of an index. Methods of security analysis employed may include proprietary stock screening, charting, fundamental analysis, technical analysis, and credit analysis.

Recent Transactions
Details Hidden

Gilead Sciences, Inc. purchases Kite Pharma, Inc.

Details Hidden

Gilead Sciences, Inc. purchases Cell Design Labs, Inc. from Kleiner Perkins Caufield & Byers LLC, Osage Partners LLC, Mission Bay Capital Management, Inc.

Details Hidden

Gilead Sciences, Inc. purchases Nimbus Apollo, Inc. from Nimbus Therapeutics LLC

Insider Transactions
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onGilead Sciences, Inc. purchases Myogen, Inc.

Accountant

Advised onGilead Sciences, Inc. purchases NeXstar Pharmaceuticals, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Kite Pharma, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Myogen, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Kite Pharma, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases CV Therapeutics, Inc.

Advisors & Consultants
Legal Advisor

Partner In Charge-Palo Alto at Cooley LLP

Legal Advisor

Partner at Cooley LLP

Legal Advisor

Partner, Palo Alto at Cooley LLP

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

General Electric Co. is a technology and financial services company that develops and manufactures products for the generation, transmission, distribution, control and utilization of electricity. Its products and services include aircraft engines, power generation, water processing, security technology, medical imaging, business and consumer financing, media content and industrial products. The company operates through the following segments: Power, Oil & Gas, Aviation, Healthcare, Transportation, Appliances & Lighting and GE Capital. The Power segment serves power generation, industrial, government and other customers worldwide with products and services related to energy production. The Oil & Gas segment supplies mission critical equipment for the global oil and gas industry, used in applications spanning the entire value chain from drilling and completion through production, liquefied natural gas and pipeline compression, pipeline inspection, and downstream processing in refineries and petrochemical plants. The Aviation segment products and services include jet engines, aerospace systems and equipment, replacement parts and repair and maintenance services for all categories of commercial aircraft; for a wide variety of military aircraft, including fighters, bombers, tankers and helicopters; for marine applications; and for executive and regional aircraft. The Healthcare segment products include diagnostic imaging systems such as magnetic resonance, computed tomography and positron emission Tomography scanners, X-ray, nuclear imaging, digital mammography and molecular imaging technologies. The Transportation segment engages in global technology and supplier to the railroad, mining, marine and drilling industries. The Appliances & Lighting segment products include major appliances and related services for products such as refrigerators, freezers, electric and gas ranges, cooktops, dishwashers, clothes washers and dryers, microwave ovens, room air conditioners, residential water systems for filtration, softening and heating, and hybrid water heaters. The GE Capital segment offers financial services and products worldwide for businesses of all sizes, services include commercial loans and leases, fleet management, financial programs, credit cards, personal loans and other financial services. The company was founded by Thomas A. Edison in 1878 and is headquartered in Boston, MA.

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Co-Founder at Caribou Biosciences, Inc.

Key Stats and Financials As of 2018
Market Capitalization
$82.8B
Total Enterprise Value
$78.3B
Earnings Per Share
$4.17
Revenue
$22.2B
Total Equity
$21.5B
Net Profit
$5.46B
Enterprise Value Sales
3.53x
TEVNet Income
14.36x
Debt TEV
0.35x
Total Debt
$27.3B
Enterprise Value EBITDAOperating
7.43x
EBITDAMargin
47.43%
EBITDA
$10.5B
Three Year Compounded Annual Growth Rate Of Revenue
-11.49%
Five Year Compounded Annual Growth Rate Of Revenue
14.63%
Non-Profit Donations & Grants
Political Donations
$3,300
2006
$2,000
2006
$2,000
2006
Investments
Details Hidden

Kolltan Pharmaceuticals, Inc. engages in the development of monoclonal antibody drugs. It focuses on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger in November 16, 2007 and is headquartered in New Haven, CT.

Details Hidden

Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.

Details Hidden

Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA.

Investors
Details Hidden

Managing Partner at Vivo Capital LLC

Suppliers
Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Johnson & Johnson Pharmaceuticals | New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Bristol-Myers Squibb Company Medical Support Services | New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

United Therapeutics Corp. Pharmaceuticals - Silver Spring, Maryland

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Awards & Honors
Rank #86
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #86
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gilead Sciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gilead Sciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Gilead Sciences, Inc..